Methysergide

CAS: 361-37-5

Ref. 3D-FM31590

Produktinformation

• Name: Methysergide
• Synonyme: (+)-N-[1-(Hydroxymethyl)propyl]-1-methyl-<span class="text-smallcaps">D</span>-lysergamide, (+)-N-[1-(Hydroxymethyl)propyl]-1-methyl-D-lysergamide, (8β)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-1,6-dimethylergoline-8-carboxamide, Deseril, Desernyl, Deseryl, Ergoline-8-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-, [8β(S)]-, Ergoline-8β-carboxamide, 9,10-didehydro-N-[1-(hydroxymethyl)propyl]-1,6-dimethyl-, Indolo[4,3-fg]quinoline, ergoline-8-carboxamide deriv., Lysergamide, N-[1-(hydroxymethyl)propyl]-1-methyl-, <span class="text-smallcaps">D</span>-, Lysergamide, N-[1-(hydroxymethyl)propyl]-1-methyl-, D-, Methysergid, Metisergido, Uml 491

Beschreibung

Methysergide is a drug that is used to treat the pain, nausea and vomiting associated with cancer, as well as Parkinson's disease. Methysergide is also used to treat the symptoms of carcinoid syndrome, which is a rare disorder in which cells from the gastrointestinal tract release serotonin. Methysergide blocks glutamate receptors on nerve cells and inhibits the release of gamma-aminobutyric acid (GABA), thereby reducing neuronal activity in certain areas of the brain. Methysergide is an antagonist at 5-HT2 receptors. It has been shown to have potent antagonist effects on these receptors in areas such as the hypothalamus and brainstem, where it may be involved in regulating pain and sleep patterns. This drug has been shown to be effective against autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. The use of methysergide for treating these diseases may be due to its ability to block substances that cause inflammation or reduce immune responses.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 353.46 g/mol
• Reinheit: Min. 95%
• Farbe/Form: Powder